Loading...

Richard Nisan Fine, MD

TitleClinical Professor of Pediatrics (Part-Time)
InstitutionUniversity of Southern California
DepartmentPediatrics
AddressIRD 105 2020 Zonal Avenue
Off Campus
Los Angeles CA 90033
Phone+1 323 226 3691
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Fine R. Tolerance in Solid-Organ Transplant. Exp Clin Transplant. 2016 11; 14(Suppl 3):1-5. PMID: 27805501.
      View in: PubMed
    2. Graves RC, Fine R. Kidney retransplantation in children following rejection and recurrent disease. Pediatr Nephrol. 2016 Dec; 31(12):2235-2247. PMID: 27048230.
      View in: PubMed
    3. Supe-Markovina K, Melquist JJ, Connolly D, DiCarlo HN, Waltzer WC, Fine R, Darras FS. Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience. Pediatr Transplant. 2014 Jun; 18(4):363-8. PMID: 24712738.
      View in: PubMed
    4. Fine R. Growth following solid organ transplantation in childhood. Clinics (Sao Paulo). 2014; 69 Suppl 1:3-7. PMID: 24860852; PMCID: PMC3884153.
    5. Upadhyay K, Fine R. Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children. Pediatr Nephrol. 2014 Aug; 29(8):1337-47. PMID: 23949630.
      View in: PubMed
    6. Mehls O, Fine R. Growth hormone treatment after renal transplantation: a promising but underused chance to improve growth. Pediatr Nephrol. 2013 Jan; 28(1):1-4. PMID: 22948320.
      View in: PubMed
    7. Ettenger RB, Tsai EW, Fine R. A paradigm shift and a few modest suggestions in the care of adolescent transplant recipients. Transplantation. 2011 Dec 15; 92(11):1191-3. PMID: 22081055.
      View in: PubMed
    8. Fine R. Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective. Pediatr Nephrol. 2010 Apr; 25(4):725-32. PMID: 20033735.
      View in: PubMed
    9. Fine R, Martz K, Stablein D. What have 20 years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children, and adolescents with end-stage renal disease? Pediatr Nephrol. 2010 Apr; 25(4):739-46. PMID: 20013293.
      View in: PubMed
    10. Fine R. Live unrelated donor renal transplantation in children--criteria of acceptability. Pediatr Nephrol. 2009 Jul; 24(7):1425; author reply 1427. PMID: 19319574.
      View in: PubMed
    11. Smith JM, Fine R, McDonald RA. Current state of pediatric renal transplantation. Front Biosci. 2008 Jan 01; 13:197-203. PMID: 17981538.
      View in: PubMed
    12. Dharnidharka VR, Talley LI, Martz KL, Stablein DM, Fine R. Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease--a report of the NAPRTCS. Pediatr Transplant. 2008 Sep; 12(6):689-95. PMID: 18179637.
      View in: PubMed
    13. Fine R. Management of growth retardation in pediatric recipients of renal allografts. Nat Clin Pract Nephrol. 2007 Jun; 3(6):318-24. PMID: 17525714.
      View in: PubMed
    14. Fine R. Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol. 2007 Apr; 22(4):496-502. PMID: 17186280; PMCID: PMC1805045.
    15. Chesney RW, Brewer E, Moxey-Mims M, Watkins S, Furth SL, Harmon WE, Fine R, Portman RJ, Warady BA, Salusky IB, Langman CB, Gipson D, Scheidt P, Feldman H, Kaskel FJ, Siegel NJ. Report of an NIH task force on research priorities in chronic kidney disease in children. Pediatr Nephrol. 2006 Jan; 21(1):14-25. PMID: 16252095.
      View in: PubMed
    16. Fine R, Stablein D. Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry. Pediatr Nephrol. 2005 Mar; 20(3):404-8. PMID: 15682317.
      View in: PubMed
    17. Seikaly MG, Ho PL, Emmett L, Fine R, Tejani A. Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. Pediatr Nephrol. 2003 Aug; 18(8):796-804. PMID: 12811650.
      View in: PubMed
    18. Neu AM, Ho PL, Fine R, Furth SL, Fivush BA. Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study. Pediatr Transplant. 2003 Jun; 7(3):217-22. PMID: 12756047.
      View in: PubMed
    19. Fine R, Ho M. The role of APD in the management of pediatric patients: a report of the North American Pediatric Renal Transplant Cooperative Study. Semin Dial. 2002 Nov-Dec; 15(6):427-9. PMID: 12437539.
      View in: PubMed
    20. Fine R, Stablein D, Cohen AH, Tejani A, Kohaut E. Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int. 2002 Aug; 62(2):688-96. PMID: 12110034.
      View in: PubMed
    21. Furth SL, Stablein D, Fine R, Powe NR, Fivush BA. Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics. 2002 May; 109(5):909-13. PMID: 11986455.
      View in: PubMed